NCT01123824 Pharmacodynamic and Pharmacokinetic Study of 2 Different Dose Regimen of Clopidogrel in CYP2C19 Genotyped Healthy Subjects Status COMPLETED Phase PHASE1
NCT01122979 Evaluation of the Safety and Efficacy of Insulin Glargine + Glulisine or Insulin Regular + NPH Insulin (Isophane Insulin) Use in Type 2 Diabetes Mellitus Patients With Moderate Renal Failure. Status COMPLETED Phase PHASE4
NCT01121848 Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer Status COMPLETED Phase PHASE3
NCT01121835 Insulins Glargine and gluLisine strAtegy Versus Premixed Insulin strAteGy: a cOmparative Study Status COMPLETED Phase PHASE4
NCT01120314 Pharmacokinetic, Pharmacodynamic and Tolerability Study of Otamixaban in Patients With Mild, Moderate and Severe Renal Impairment Status COMPLETED Phase PHASE1
NCT01118728 Extension Study for Long Term Evaluation of SAR153191 (REGN88) in Patients With Ankylosing Spondylitis Status TERMINATED Phase PHASE2
NCT01117350 Efficacy Assessment of Insulin Glargine Versus LiraglutidE After Oral Agents Failure Status COMPLETED Phase PHASE4
NCT01113333 Safety, Tolerability and Pharmacokinetics of SAR113945 Following Intra-articular Administration in Patients With Knee Osteoarthritis Status COMPLETED Phase PHASE1
NCT01111513 The Influence of the Femoral Nerve Block on Quadriceps Strength Status COMPLETED Phase NA
NCT01110291 Study of Usefulness of Genotyping to Predict Docetaxel Exposure and Adverse Events Status COMPLETED Phase N/A
NCT01107756 A Clinical Trial of Patients With Solid Tumours Receiving Granulocyte Colony Stimulating Factor as Primary Prophylaxis for Chemotherapy-induced Neutropenia, in a Docetaxel Based Regimen Status COMPLETED Phase PHASE4
NCT01105559 Antibody Persistence in Healthy Children After Primary and Booster DTaP-IPV-Hep B-PRP-T Vaccine or Control Vaccine Status COMPLETED Phase N/A
NCT01099436 Neo-Adjuvant Chemotherapy (TAC) With or Without Zoledronic Acid in Treating HER2-negative Breast Cancer Patients Status COMPLETED Phase PHASE3
NCT01095302 Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 Combined With Docetaxel and Cisplatin in Patients With Solid Tumors Status COMPLETED Phase PHASE1
NCT01089569 Continuous Glucose Monitoring Evaluation of Exenatide Twice Daily Versus Insulin Glargine Status COMPLETED Phase NA
NCT01087658 Oral Glutamine in the Prevention of Oxaliplatin-induced Neurotoxicity Status COMPLETED Phase PHASE3
NCT01087021 Effect of Cabazitaxel on the QTc Interval in Cancer Patients Status COMPLETED Phase PHASE1